What does CUSIP 040334104 represent in this 13F holders report?

CUSIP 040334104 is the security identifier for ARDS - Aridis Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ARDS - Aridis Pharmaceuticals, Inc. - Common Stock in Q1 2024?

No institutional holders were reported for ARDS - Aridis Pharmaceuticals, Inc. - Common Stock in Q1 2024; review adjacent reporting periods for trend context.

Aridis Pharmaceuticals, Inc. - Common Stock (ARDS)

CUSIP: 040334104

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock
Shares outstanding: 44,586,623
Total 13F shares: 0
Share change: -150
Total reported value: $0
Number of holders: 0
Value change: -$10
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 040334104?
CUSIP 040334104 identifies ARDS - Aridis Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q4 2023

Recent filing periods for CUSIP 040334104:

Q4 2025 Q3 2025 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022

Aridis Pharmaceuticals, Inc. - Common Stock (ARDS)

Q1 2024 13F Holders as of 31 Mar 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of ARDS - Aridis Pharmaceuticals, Inc. - Common Stock as of Q1 2024.